Covered recipient · General Payments record
FAYSAL A YAFI
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$329,498.73
- Reported across 264 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $26,448.38 | 7 |
| Honoraria | $7,000.00 | 3 |
| Food and Beverage | $1,490.21 | 21 |
| Travel and Lodging | $1,191.69 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| COLOPLAST CORP | $21,292.36 | 25 |
| Antares Pharma, Inc. | $11,788.25 | 6 |
| Laborie Medical Technologies Corp. | $2,049.67 | 3 |
| Verity Pharmaceuticals Inc. | $1,000.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $5,598.38 | 04/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1146493284 | CMS |
| Antares Pharma, Inc. | $54.65 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146493288 | CMS |
| Antares Pharma, Inc. | $129.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146493293 | CMS |
| Antares Pharma, Inc. | $3,000.00 | 06/11/2024 | Honoraria | Undisputed | 01/23/2026 | 1146493297 | CMS |
| Antares Pharma, Inc. | $5.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146493302 | CMS |
| Antares Pharma, Inc. | $3,000.00 | 11/02/2024 | Honoraria | Undisputed | 01/23/2026 | 1146493306 | CMS |
| COLOPLAST CORP | $576.19 | 02/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117443965 | CMS |
| COLOPLAST CORP | $34.10 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443991 | CMS |
| COLOPLAST CORP | $23.61 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443993 | CMS |
| COLOPLAST CORP | $19.67 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443995 | CMS |
| COLOPLAST CORP | $19.20 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443979 | CMS |
| COLOPLAST CORP | $31.49 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443981 | CMS |
| COLOPLAST CORP | $172.37 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443987 | CMS |
| COLOPLAST CORP | $48.90 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443973 | CMS |
| COLOPLAST CORP | $22.20 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443975 | CMS |
| COLOPLAST CORP | $32.63 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117443977 | CMS |
| COLOPLAST CORP | $270.00 | 03/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117443983 | CMS |
| COLOPLAST CORP | $61.28 | 03/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117443985 | CMS |
| COLOPLAST CORP | $284.22 | 03/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1117443989 | CMS |
| COLOPLAST CORP | $8,875.00 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117444047 | CMS |
| COLOPLAST CORP | $83.60 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444041 | CMS |
| COLOPLAST CORP | $175.00 | 06/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117444049 | CMS |
| COLOPLAST CORP | $177.09 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444045 | CMS |
| COLOPLAST CORP | $40.76 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444053 | CMS |
| COLOPLAST CORP | $55.44 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444055 | CMS |
| COLOPLAST CORP | $5,750.00 | 09/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117444077 | CMS |
| COLOPLAST CORP | $4,000.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117444079 | CMS |
| COLOPLAST CORP | $168.90 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444061 | CMS |
| COLOPLAST CORP | $10.86 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444063 | CMS |
| COLOPLAST CORP | $250.00 | 10/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117444075 | CMS |
| COLOPLAST CORP | $109.85 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117444065 | CMS |
| Laborie Medical Technologies Corp. | $105.86 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154325745 | CMS |
| Laborie Medical Technologies Corp. | $1,800.00 | 06/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154325747 | CMS |
| Laborie Medical Technologies Corp. | $143.81 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154325749 | CMS |
| Verity Pharmaceuticals Inc. | $1,000.00 | 10/24/2024 | Honoraria | Undisputed | 01/23/2026 | 1080601503 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.